Psychiatry
Guideline: Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder
31 Jan, 2020 | 01:03h | UTCCommentary: New clinical practice guideline for complex ADHD in children and adolescents – Boston Children’s Hospital (free)
Related: AAP Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (free)
Study: First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations
29 Jan, 2020 | 08:16h | UTCFirst-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations – JAMA (free for a limited period)
Commentary: Modafinil in First Trimester Associated with Birth Defects – NEJM Journal Watch (free)
Position Statement: Use of Drugs in ADHD in Children and Adolescents with a Known Heart Disease, As Well as in the General Pediatric Population
28 Jan, 2020 | 08:48h | UTCRelated: AAP Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (free)
Meta-Analysis: Optimal Doses of Antidepressants in Dependence on Age
26 Jan, 2020 | 22:29h | UTCRelated Meta-analysis: Optimal Dose of Antidepressants in Major Depression – The Lancet Psychiatry (free study and commentaries)
Evidence-based Guidelines on the Therapeutic use of Repetitive Transcranial Magnetic Stimulation
23 Jan, 2020 | 02:05h | UTC
[Abstract Only] Systematic Review: No Benefit from Flexible Titration Above Minimum Licensed Dose in Prescribing Antidepressants for Major Depression
22 Jan, 2020 | 09:27h | UTCNo benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review – Acta Psychiatrica Scandinavica (link to abstract – $ for full-text)
Related Meta-analysis: Optimal Dose of Antidepressants in Major Depression – The Lancet Psychiatry (free study and commentaries)
Cohort Study: Second-generation Antipsychotics and Pregnancy Complications
22 Jan, 2020 | 09:18h | UTC
[Abstract Only] Randomized Trial: Effectiveness of Mirtazapine as Add-on to Paroxetine vs. Paroxetine or Mirtazapine Monotherapy in Patients with Depression with Early Non-response to Paroxetine
22 Jan, 2020 | 09:08h | UTCEffectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial – Psychological Medicine (link to abstract – $ for full-text)
Position Statement: Mental Health Issues and Psychological Factors in Athletes
19 Jan, 2020 | 20:59h | UTCMental health issues and psychological factors in athletes: detection, management, effect on performance and prevention: American Medical Society for Sports Medicine Position Statement—Executive Summary – British Journal of Sports Medicine (free for a limited period)
Commentary: Sports Medicine Group Issues Guidance on Athletes’ Mental Health – Reuters / Medscape (free registration required)
Systematic Review: Pharmacological Interventions for Treatment‐resistant Depression in Adults
19 Jan, 2020 | 20:29h | UTCPharmacological interventions for treatment‐resistant depression in adults – Cochrane Library (free)
Summary: Are there effective medications for treating depression that does not improve with the first medication used? – Cochrane Library (free)
Nutritional Psychiatry: Towards Improving Mental Health by What You Eat
17 Jan, 2020 | 02:13h | UTCCommentary: Diet and Mental Health: The Evidence to Date – Medscape (free registration required)
A Network Meta‐analysis of the Effects of Psychotherapies, Pharmacotherapies and their Combination in the Treatment of Adult Depression
16 Jan, 2020 | 04:04h | UTC
[Abstract Only] Study: Diabetes in Adolescents Linked to Greatly Increased Risk of Suicide Behavior
16 Jan, 2020 | 03:20h | UTCRisk of Psychiatric Disorders and Suicide Attempts in Emerging Adults With Diabetes – Diabetes Care (link to abstract – $ for full-text)
Commentary: Suicide rates sharply higher than average in teens, young adults with diabetes – Reuters (free)
The use of Antidepressants in Oncology: A Review and Practical Tips for Oncologists
16 Jan, 2020 | 02:39h | UTC
Randomized Trial: Efficacy and Safety of Lumateperone for Treatment of Schizophrenia
14 Jan, 2020 | 00:34h | UTCEditorial: The Potential Role of Lumateperone—Something Borrowed? Something New? – JAMA Psychiatry (free for a limited period)
Related Commentary on Twitter
In a Phase 3 trial, lumateperone (42mg) demonstrated significant efficacy for improving the symptoms of schizophrenia with a favorable safety profile. https://t.co/0eukuf1Qrf
— JAMA Psychiatry (@JAMAPsych) January 8, 2020
Systematic Review: Patient Safety in Inpatient Mental Health Settings
14 Jan, 2020 | 00:18h | UTCPatient safety in inpatient mental health settings: a systematic review – BMJ Open (free)
Review – Beyond Depression: Other Uses for Tricyclic Antidepressants
9 Jan, 2020 | 01:21h | UTCBeyond depression: Other uses for tricyclic antidepressants – Cleveland Clinic Journal of Medicine (free)
[Abstract Only] Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
8 Jan, 2020 | 21:51h | UTCDose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia – American Journal of Psychiatry (link to abstract – $ for full-text)
FDA Safety Communication: Gabapentinoids may Cause Serious Respiratory Problems in Predisposed Patients
8 Jan, 2020 | 01:10h | UTCCommentaries: Gabapentinoids Linked to Respiratory Problems in Certain Patients – NEJM Journal Watch (free) AND FDA warns gabapentin, pregabalin may cause serious breathing problems – The Hospitalist (free)
Consensus Statement: Insufficient Evidence to Recommend Brain Health Supplements
8 Jan, 2020 | 00:57h | UTCCommentary: AARP report: Insufficient evidence that dietary supplements benefit brain health – Science-Based Medicine (free)
Meta-Analysis: Comparative Effects of 18 Antipsychotics on Metabolic Function in Patients with Schizophrenia
8 Jan, 2020 | 00:56h | UTCCommentaries: Insights into metabolic dysregulations associated with antipsychotics – The Lancet Psychiatry (free) AND Not all antipsychotics increase the risk of diabetes and raise cholesterol – some may be protective – The Conversation (free)
Randomized Trial: Lemborexant vs. Placebo vs. Zolpidem Tartrate Extended Release for the Treatment of Older Adults with Insomnia Disorder
5 Jan, 2020 | 13:27h | UTCCommentary: Insomnia: Lemborexant With Placebo Vs Zolpidem Tartrate Extended Release – MedicalResearch.com (free)
AAP Clinical Report: Identification, Evaluation, and Management of Children with Autism Spectrum Disorder
5 Jan, 2020 | 12:58h | UTCIdentification, Evaluation, and Management of Children With Autism Spectrum Disorder – Pediatrics (free)
Commentaries: American Academy of Pediatrics Report Provides Sweeping Review of Evidence Concerning Autism Spectrum Disorder – American Academy of Pediatrics (free) AND Report: Pediatricians Should Be Ready to Screen Youngest Children for Autism – AJMC (free)
Analysis: Prioritizing Action on Alcohol for Health and Development
12 Dec, 2019 | 08:13h | UTCPrioritising action on alcohol for health and development – The BMJ (free)
See Complete Collection: Solutions for Prevention and Control of Non-communicable Diseases – WHO / The BMJ (free)
Related: WHO Global Status Report on Alcohol and Health 2018 (free report and commentaries) AND Alcohol Use and Burden for 195 Countries and Territories – The Lancet (free study and commentaries)
Meta-Analysis: Prevalence of Problematic Smartphone Usage and Associated Mental Health Outcomes Amongst Children and Young People
1 Dec, 2019 | 21:56h | UTCCommentaries: An estimated 1 in 4 children and young people have problematic smartphone usage – King’s College London (free) AND Expert reaction to problematic smart phone use in young people – Science Media Centre (free) AND Teens aren’t addicted to their phones – but we like to think they are – NewScientist (free)